Real Life Evaluation of the Multi-organ Effects of Lumacaftor/Ivacaftor on F508del Homozygous Cystic Fibrosis Patients.

NCT04623879 · clinicaltrials.gov ↗

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Lumacaftor, Ivacaftor Drug Combination

Sponsor

Carmel Medical Center